Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
暂无分享，去创建一个
J. Schlom | R. Madan | Marijo Bilusic | S. Rabizadeh | P. Soon-Shiong | J. Marté | J. Gulley | C. Jochems | R. Donahue | F. Karzai | C. Palena | J. Redman | Houssein Abdul Sater | Y. Tsai | J. Strauss | C. Floudas | S. McMahon